From March 24, 2024 to March 31, 2024, the company has repurchased 3,275,199 shares, representing 6.96% for $1,000 million. With this, the company has completed the repurchase of 3,275,199 shares, representing 6.96% for $1,000 million under the buyback announced on March 25, 2024.
Market Closed -
Other stock markets
|
5-day change | 1st Jan Change | ||
276.3 USD | +0.41% | +1.24% | +25.64% |
Jun. 03 | Liquidia's Yutrepia Launch Cleared as Court Denies Injunction | MT |
May. 16 | United Therapeutics Insider Sold Shares Worth $545,800, According to a Recent SEC Filing | MT |
EPS Revisions
1st Jan change | Capi. | |
---|---|---|
+25.64% | 12.26B | |
+48.64% | 56.65B | |
-6.44% | 39.44B | |
+37.18% | 39.03B | |
+14.28% | 26.75B | |
-11.17% | 26.86B | |
-21.40% | 19.03B | |
+0.96% | 12.28B | |
+27.04% | 12.04B | |
-12.04% | 10.71B |
- Stock Market
- Equities
- UTHR Stock
- News United Therapeutics Corporation
- Tranche Update on United Therapeutics Corporation's Equity Buyback Plan announced on March 25, 2024.